LSE : 0I7E.L
$3.43 (1.47%)
LSE
Javier J. Rodriguez
Medical - Care Facilities
Healthcare
0I7E.L
78000
US
USD
-17.50
1.42
1.37
0.25
0.00
$13.64B
1.09
-21.00
10.12
22.15
$9.51
$746.8M
5.65%
10.13%
-133.12%
4.47%
23.20
-12.00
-12.00
3/5
22 Analysts
%
1.84
7/9
$1.2B
$17.5B
$16.45B
$1.97B
No key metrics data available.
| Name | Title |
|---|---|
| David Maughan | Chief Operating Officer of DaVita Kidney Care |
| James O. Hearty | Chief Compliance Officer |
| Partha Das | Chief Medical Officer of DaVita International |
| Christopher Michael Berry | Group Vice President & Chief Accounting Officer |
| Nic Eliason | Group Vice President of Investor Relations |
| Jeffrey Allen Giullian | Chief Medical Officer of Kidney Care |
| Javier J. Rodriguez | Chief Executive Officer & Executive Director |
| Joel Ackerman | Chief Financial Officer & Treasurer |
| Misha Palecek | Chief Transformation Officer of U.S. Kidney Care Business |
| Kathleen Alyce Waters | Chief Legal & Public Affairs Officer |
| Stephanie Hendrickson | Chief People Officer |
No votes yet today — be the first to share your view!
About DaVita Inc. (LSE:0I7E.L) Stock
DaVita Inc. specializes in delivering vital kidney dialysis treatments to individuals afflicted with chronic kidney failure. The company manages numerous outpatient dialysis clinics, where it not only conducts dialysis sessions but also offers essential laboratory testing services. Its comprehensive offerings extend to outpatient, hospital inpatient, and at-home hemodialysis. Furthermore, DaVita operates its own clinical laboratories, performing standard dialysis-related tests and other prescribed analyses for ESRD patients, alongside providing management and administrative support to its network of outpatient centers. Beyond core dialysis, DaVita delivers a suite of integrated care services, including disease management for approximately 23,000 patients (within both risk-based and other i ... ntegrated arrangements), vascular access procedures, clinical research initiatives, physician consultation, and holistic kidney care programs. By the close of 2021, DaVita maintained a substantial presence, with 2,815 outpatient dialysis facilities across the United States serving around 203,100 patients, and an additional 339 centers in 10 international markets supporting roughly 39,900 patients. In the U.S., it also delivered acute inpatient dialysis services, complete with laboratory support, in approximately 850 hospitals. Originally incorporated in 1994 and headquartered in Denver, Colorado, the company adopted its current name, DaVita Inc., in September 2016, having previously operated as DaVita HealthCare Partners Inc.
Frequently Asked Questions
What is the current DaVita Inc. (0I7E.L) stock price?
DaVita Inc.(LSE:0I7E.L) stock price is $236.46 in the last trading session. During the trading session, 0I7E.L stock reached the peak price of $238.4 while $71.565 was the lowest point it dropped to. The percentage change in 0I7E.L stock occurred in the recent session was 1.47% while the dollar amount for the price change in 0I7E.L stock was $3.43.
0I7E.L's industry and sector of operation?
The LSE listed 0I7E.L is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
Who are the executives of 0I7E.L?
David Maughan
| Chief Operating Officer of DaVita Kidney Care
James O. Hearty
| Chief Compliance Officer
Partha Das
| Chief Medical Officer of DaVita International
Christopher Michael Berry
| Group Vice President & Chief Accounting Officer
Nic Eliason
| Group Vice President of Investor Relations
How many employees does 0I7E.L have?
Number of 0I7E.L employees currently stands at 78000. 0I7E.L operates from 2000 16th Street, Denver, CO 80202, US.
Link for 0I7E.L official website?
Official Website of 0I7E.L is: https://www.davita.com
How do I contact 0I7E.L?
0I7E.L could be contacted at phone #720 631 2100 and can also be accessed through its website. 0I7E.L operates from 2000 16th Street, Denver, CO 80202, US.
How many shares of 0I7E.L are traded daily?
The average number of 0I7E.L shares traded daily for last 3 months was 1.55K.
What is the market cap of 0I7E.L currently?
The market value of 0I7E.L currently stands at $16.84B with its latest stock price at $236.46